Type to search

News

Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference

Share
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference | Pharmtech Focus

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.

Fireside chat details:
Date: Tuesday, April 13, 2021
Time: 2:30 – 3:20 p.m. Eastern Time (ET)
Panel title: COVID-19 Vaccines – Staying Ahead of the Curve
Novavax participant: Vivek Shinde, M.D., M.P.H., Vice President, Clinical Development
This event is open to Goldman Sachs clients.
Tags:

Companies in this post:

You Might also Like

Related Stories

Next Up